Table: Chugai Pharm -9-MTH group results (IFRS)

Chugai Pharmaceutical

25/10/2024 09:00

Oct 25 (Reuters)- 
              Chugai Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   9 months ended      9 months ended       Year to 
                  Sep 30, 2024        Sep 30, 2023     Dec 31, 2024 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              868.54              837.56                     
                   (+3.7 pct)          (+2.0 pct)                   
  Operating          418.60              317.60                     
                   (+31.8 pct)         (-17.3 pct)                  
  Pretax
  Net                295.76              234.27                     
                   (+26.2 pct)         (-13.9 pct)                  
  EPS Basic        179.75 yen          142.40 yen                   
  EPS Diluted      179.72 yen          142.37 yen                   
  Ann Div                               80.00 yen                   
  -Q2 Div           41.00 yen           40.00 yen                   
  -Q4 Div                               40.00 yen                   
 
  NOTE - Chugai Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4519.T